The Experts below are selected from a list of 1017 Experts worldwide ranked by ideXlab platform

Robert H Mathog - One of the best experts on this subject based on the ideXlab platform.

  • Platysma Muscle cervical fascia sternocleidomastoid Muscle pcs flap for parotidectomy
    Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 1999
    Co-Authors: Robert H Mathog
    Abstract:

    Background Parotidectomy is useful in the treatment of benign and malignant neoplasms of the parotid gland, but often leads to sequelae of facial deformity and Frey's syndrome. This paper presents a retrospective review of parotidectomy results in 21 consecutive patients treated with either traditional techniques or with the rotation and advancement of combined Platysma Muscle-cervical fascia-sternocleidomastoid flap (PCS). Methods The surgical procedures utilized for removal and reconstruction are described. Information on appearance and function was obtained by analysis of hospital and office records and telephone questionnaire for patients with and without the flap. Results Of the 21 patients eligible for this study, only 9 of 10 patients with the PCS flap and 10 of 11 patients without the flap provided sufficient data for analysis. In the flap group all 9 patients either noted a mild fullness on the operated side or no difference between sides. In the nonflap group, 4 patients felt they had a moderate depression, 2 patients noted a mild depression, and 4 patients noted no difference between sides. Frey's syndrome was classified as mild in 2 patients in the PCS group, whereas in the nonflap group, 4 patients thought it was mild and 1, severe. Complications were rare in either group. Conclusion The PCS flap prevents deformity and contributes to patient satisfaction following parotidectomy. The flap helps to prevent Frey's syndrome and is not associated with an increase in postoperative complications. The flap is recommended following removal of nonrecurrent or low-grade malignant parotid tumors. © 1999 John Wiley & Sons, Inc. Head Neck 21: 428– 433, 1999.

  • Platysma Muscle‐cervical fascia‐sternocleidomastoid Muscle (PCS) flap for parotidectomy
    Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 1999
    Co-Authors: Robert H Mathog
    Abstract:

    Background Parotidectomy is useful in the treatment of benign and malignant neoplasms of the parotid gland, but often leads to sequelae of facial deformity and Frey's syndrome. This paper presents a retrospective review of parotidectomy results in 21 consecutive patients treated with either traditional techniques or with the rotation and advancement of combined Platysma Muscle-cervical fascia-sternocleidomastoid flap (PCS). Methods The surgical procedures utilized for removal and reconstruction are described. Information on appearance and function was obtained by analysis of hospital and office records and telephone questionnaire for patients with and without the flap. Results Of the 21 patients eligible for this study, only 9 of 10 patients with the PCS flap and 10 of 11 patients without the flap provided sufficient data for analysis. In the flap group all 9 patients either noted a mild fullness on the operated side or no difference between sides. In the nonflap group, 4 patients felt they had a moderate depression, 2 patients noted a mild depression, and 4 patients noted no difference between sides. Frey's syndrome was classified as mild in 2 patients in the PCS group, whereas in the nonflap group, 4 patients thought it was mild and 1, severe. Complications were rare in either group. Conclusion The PCS flap prevents deformity and contributes to patient satisfaction following parotidectomy. The flap helps to prevent Frey's syndrome and is not associated with an increase in postoperative complications. The flap is recommended following removal of nonrecurrent or low-grade malignant parotid tumors. © 1999 John Wiley & Sons, Inc. Head Neck 21: 428– 433, 1999.

Claudio Cardoso De Castro - One of the best experts on this subject based on the ideXlab platform.

  • The changing role of Platysma in face lifting.
    Plastic and reconstructive surgery, 2000
    Co-Authors: Claudio Cardoso De Castro
    Abstract:

    Since the 1970s, surgical procedures on Platysma Muscle, aiming to achieve better results in face lifting, became popular and turned out to be an important surgical step for the plastic surgeon. Many plastic surgeons have contributed to the topic throughout these years, as several articles on the subject have been published. Articles dealing with Platysma Muscle still bring great interest among plastic surgeons. My concern with Platysma Muscle began in the mid-1970s and since then has grown continuously. I have steadily been studying the importance of the Platysma Muscle in the surgeries for facial rejuvenation, involving its anatomy, the techniques proposed, the results obtained, the recommendations for the best surgical procedure for each patient, and the complications. My experience and studies regarding Platysma Muscle, and the contributions I have brought into this field, are thoroughly described and discussed in this article.

  • Anatomical Variations Analysis of the External Jugular Vein, Great Auricular Nerve, and Posterosuperior Border of the Platysma Muscle
    Aesthetic plastic surgery, 1997
    Co-Authors: José Horácio Aboudib, Claudio Cardoso De Castro
    Abstract:

    This article describes the observations collected from the dissection of 10 nonformalinized cadavers analyzed in respect to the anatomical relation variations between the external jugular vein, the great auricular nerve, and the posterosuperior border of the Platysma Muscle.

  • Superficial musculoaponeurotic system-Platysma: a continuous study.
    Annals of plastic surgery, 1991
    Co-Authors: Claudio Cardoso De Castro
    Abstract:

    Taking advantage of anatomical knowledge, in this report we suggest the benefits of an ample superficial musculoaponeurotic system undermining reaching the insertions of Platysma Muscle in the cutaneous Muscles of the mouth and chin. This dissection is followed by an upward pull of the superficial musculoaponeurotic system-Platysma on the face and a posterosuperior pull on the neck. The described procedure is recommended for patients presenting with drooping chin and lateral gravity bags. The method was performed in 84 of 148 patients, with excellent results.

Sven Oliver Müller - One of the best experts on this subject based on the ideXlab platform.

  • Randomized clinical trial of Platysma Muscle suture versus no suture for wound closure after thyroid surgery.
    The British journal of surgery, 2018
    Co-Authors: M. Senne, R. Zein, Claudius Falch, Andreas Kirschniak, Alfred Koenigsrainer, Sven Oliver Müller
    Abstract:

    Background Suturing the Platysma Muscle during wound closure after thyroid surgery is frequently described in the literature. There is no prospective evidence to support its use or benefit. The aim of this study was to evaluate how a Platysma Muscle suture influences initial postoperative pain following thyroid surgery. Methods Patients were assigned randomly to receive a Platysma suture or no Platysma suture in this prospective, patient-blinded trial. The duration of follow-up was 6 months. The primary endpoint was wound-specific pain 24 h after thyroid resection. Secondary endpoints were intraoperative and perioperative analgesia requirement, postoperative pain and complications until postoperative day 14, and Patient and Observer Scar Assessment Score (POSAS) 6 months after surgery. Results Forty-one patients were randomized to each group. Visual analogue scale scores for wound-specific pain were lower in patients without a Platysma suture 24 h after surgery (mean(s.d.) 3·15(1·46) versus 2·17(1·41) in groups with and without suture respectively; P = 0·002). There were no differences in the perioperative and postoperative need for analgesics, postoperative wound complications or cervical scar cosmesis 6 months after surgery (mean(s.d.) POSAS 23·99(9·53) versus 26·51(8·69); P = 0·148). Conclusion Omitting the Platysma Muscle suture after thyroid surgery resulted in less wound-specific pain initially, with no difference in postoperative wound complications or cosmetic results. Registration number: NCT02951000 (http://www.clinicaltrials.gov).

Elena Dalla Toffola - One of the best experts on this subject based on the ideXlab platform.

  • Platysma synkinesis in facial palsy and botulinum toxin type A.
    The Laryngoscope, 2014
    Co-Authors: Anna Dall'angelo, Silvia Mandrini, Vittorio Sala, Chiara Pavese, Ettore Carlisi, Mario Comelli, Elena Dalla Toffola
    Abstract:

    Objectives/Hypothesis Facial synkinesis is a well-known disabling occurrence following severe facial palsy. Platysma Muscle, innervated by the facial nerve, can be involved in synkinesis as well, but thus far has been little investigated. The aim of our study is to evaluate the presence of Platysma synkinesis and its clinical evolution after onabotulinumtoxinA (BoNT-A) (Botox®; Allergan Pharmaceuticals, Irvine, CA) injections. Study Design Retrospective study. Methods Sixty-nine patients were treated for synkinesis following facial palsy. Of those, 45 were affected by Platysma synkinesis and thus were injected in the Platysma Muscle. The total number of sessions was 124. The Sunnybrook Facial Grading System (SFGS) and a specific Platysmal evaluation for the presence and severity of synkinesis and local symptoms were performed before and after BoNT-A treatments. Results Platysma synkinesis was present in 65.2% of the sample and was associated with subjective complaints in 85.5% of the cases. The facial expressions more related to Platysma synkinesis were snarl, followed by open-mouth smile and lip pucker. After each BoNT-A treatment, there was an improvement in facial symmetry at rest and during voluntary movements, a global reduction of synkinesis, and a specific reduction of synkinesis and symptoms related to the Platysma. No adverse reaction to BoNT-A occurred. Conclusion Platysma involvement represents a recurring and symptomatic problem in patients affected by synkinetic recovery following facial palsy. After BoNT-A injections, there is a reduction in Platysma synkinesis and related symptoms. Level of Evidence 4. Laryngoscope, 124:2513–2517, 2014

M. Senne - One of the best experts on this subject based on the ideXlab platform.

  • Randomized clinical trial of Platysma Muscle suture versus no suture for wound closure after thyroid surgery.
    The British journal of surgery, 2018
    Co-Authors: M. Senne, R. Zein, Claudius Falch, Andreas Kirschniak, Alfred Koenigsrainer, Sven Oliver Müller
    Abstract:

    Background Suturing the Platysma Muscle during wound closure after thyroid surgery is frequently described in the literature. There is no prospective evidence to support its use or benefit. The aim of this study was to evaluate how a Platysma Muscle suture influences initial postoperative pain following thyroid surgery. Methods Patients were assigned randomly to receive a Platysma suture or no Platysma suture in this prospective, patient-blinded trial. The duration of follow-up was 6 months. The primary endpoint was wound-specific pain 24 h after thyroid resection. Secondary endpoints were intraoperative and perioperative analgesia requirement, postoperative pain and complications until postoperative day 14, and Patient and Observer Scar Assessment Score (POSAS) 6 months after surgery. Results Forty-one patients were randomized to each group. Visual analogue scale scores for wound-specific pain were lower in patients without a Platysma suture 24 h after surgery (mean(s.d.) 3·15(1·46) versus 2·17(1·41) in groups with and without suture respectively; P = 0·002). There were no differences in the perioperative and postoperative need for analgesics, postoperative wound complications or cervical scar cosmesis 6 months after surgery (mean(s.d.) POSAS 23·99(9·53) versus 26·51(8·69); P = 0·148). Conclusion Omitting the Platysma Muscle suture after thyroid surgery resulted in less wound-specific pain initially, with no difference in postoperative wound complications or cosmetic results. Registration number: NCT02951000 (http://www.clinicaltrials.gov).